| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $736.5M | -7.0% |
| Cost of Revenue | $662.8M | -9.6% |
| R&D Expense | $38.8M | -4.7% |
| SG&A Expense | $145.3M | +5.6% |
| Operating Income | -$203.4M | +21.4% |
| Pre-tax Income | -$290.7M | +14.1% |
| Income Tax | $3.5M | +185.7% |
| Net Income | -$294.2M | +13.4% |
| EPS (Basic) | -$0.42 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $133.9M | -38.1% |
| Accounts Receivable | $24.2M | -25.0% |
| Inventory | $11.6M | -4.9% |
| Current Assets | $249.4M | -24.9% |
| Total Assets | $968.8M | -16.3% |
| Current Liabilities | $907.6M | -1.1% |
| Long-term Debt | $671.3M | -11.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$166.3M | -113.5% |
| Capital Expenditures | $93.6M | -23.8% |
| Investing Cash Flow | $180.4M | +486.4% |
| Financing Cash Flow | -$98.5M | -225.2% |
| Free Cash Flow | -$259.9M | -29.5% |
| +14.3% |
| EPS (Diluted) | -$0.42 | +14.3% |
| Total Liabilities |
| $1.36B |
| +0.5% |
| Stockholders' Equity | -$392.1M | -94.0% |